Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2010 | 1 |
2011 | 4 |
2012 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Bioinformatic tools for identifying disease gene and SNP candidates.
Methods Mol Biol. 2010;628:307-19. doi: 10.1007/978-1-60327-367-1_17.
Methods Mol Biol. 2010.
PMID: 20238089
Free PMC article.
Review.
Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer.
Lu WJ, Desta Z, Flockhart DA.
Lu WJ, et al.
Breast Cancer Res Treat. 2012 Jan;131(2):473-81. doi: 10.1007/s10549-011-1428-z. Epub 2011 Mar 9.
Breast Cancer Res Treat. 2012.
PMID: 21390495
Item in Clipboard
The emerging role of electronic medical records in pharmacogenomics.
Wilke RA, Xu H, Denny JC, Roden DM, Krauss RM, McCarty CA, Davis RL, Skaar T, Lamba J, Savova G.
Wilke RA, et al.
Clin Pharmacol Ther. 2011 Mar;89(3):379-86. doi: 10.1038/clpt.2010.260. Epub 2011 Jan 19.
Clin Pharmacol Ther. 2011.
PMID: 21248726
Free PMC article.
Review.
Item in Clipboard
Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms.
Lu WJ, Ferlito V, Xu C, Flockhart DA, Caccamese S.
Lu WJ, et al.
Chirality. 2011 Nov;23(10):891-6. doi: 10.1002/chir.21005. Epub 2011 Sep 22.
Chirality. 2011.
PMID: 21953762
Free PMC article.
Item in Clipboard
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, Miller KD; ECOG 2100.
Schneider BP, et al.
J Clin Oncol. 2008 Oct 1;26(28):4672-8. doi: 10.1200/JCO.2008.16.1612.
J Clin Oncol. 2008.
PMID: 18824714
Free PMC article.
Clinical Trial.
Item in Clipboard
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents.
Lu WJ, Xu C, Pei Z, Mayhoub AS, Cushman M, Flockhart DA.
Lu WJ, et al.
Breast Cancer Res Treat. 2012 May;133(1):99-109. doi: 10.1007/s10549-011-1699-4. Epub 2011 Aug 4.
Breast Cancer Res Treat. 2012.
PMID: 21814747
Item in Clipboard
Functional characterization of a genetic polymorphism in the promoter of the ESR2 gene.
Philips S, Richter A, Oesterreich S, Rae JM, Flockhart DA, Perumal NB, Skaar TC.
Philips S, et al.
Horm Cancer. 2012 Apr;3(1-2):37-43. doi: 10.1007/s12672-011-0086-2.
Horm Cancer. 2012.
PMID: 21979797
Free PMC article.
Item in Clipboard
Cite
Cite